Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:16 PM ET 8-K
Divestiture Avalanche Treasury Corp AVAT

Avalanche Treasury Divestiture to Avalanche, Inc. for $15M

Avalanche Treasury Corporation sold approximately 2.08 million AVAX tokens to the Avalanche (BVI) Foundation for $15 million in gross proceeds. The transaction involved the company's longest-dated locked tokens and the proceeds will be used to reduce debt and for general corporate purposes.

Value
$15M
Counterparty
Avalanche (BVI), Inc.
4:16 PM ET 8-K
Contract Win Apimeds Pharmaceuticals US, Inc. APUS

Apimeds Pharmaceuticals US Wins Contract from AQUAE Holdings Pte. Ltd.

Apimeds Pharmaceuticals' subsidiary MindWave Innovations entered into two 12-month technology services agreements to deploy its MindChain blockchain infrastructure. The first agreement with AQUAE Holdings involves powering AQUAEChain for environmental credit management, while the second with Flash Sports & Media involves creating FlashChain for digital broadcasting rights and video assets.

Counterparty
AQUAE Holdings Pte. Ltd. and Flash Sports & Media Holdings, Inc.
Term
12 months
4:13 PM ET 8-K
Capital Raise Dynex Capital Inc DX

Dynex Capital Capital Raise of $120M

Dynex Capital, Inc. closed an underwritten public offering of 4,800,000 shares of its 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock at a liquidation preference of $25.00 per share. The company raised $120 million in gross proceeds (excluding the underwriters' option for an additional 720,000 shares) to be used for general corporate purposes, including acquiring mortgage-backed securities.

Value
$120M
Counterparty
Morgan Stanley & Co. LLC
4:12 PM ET 8-K
Contract Win Lifecore Biomedical, Inc. \De\ LFCR

Lifecore Biomedical, Inc. \De\ Wins Contract from Alcon Research, LLC

Lifecore Biomedical extended its contract manufacturing agreement with Alcon Research, LLC, pushing the expiration date from 2031 to December 31, 2034. The amendment establishes Alcon's minimum purchase obligations through the new term and includes a non-compete provision regarding certain products starting in November 2026.

Counterparty
Alcon Research, LLC
Term
through Dec 2034
4:12 PM ET 8-K
Capital Raise Bluerock Acquisition Corp. II BRRK

Bluerock Acquisition Corp. II Capital Raise of $172M

Bluerock Acquisition Corp. II closed its initial public offering (IPO) of 17,250,000 units at $10.00 per unit, which included the full exercise of the underwriter's over-allotment option. The offering generated gross proceeds of $172.5 million for the newly formed blank check company (SPAC).

Value
$172M
Counterparty
BTIG, LLC
4:11 PM ET 8-K
Clinical Trial Data Dyne Therapeutics, Inc. DYN

Dyne Therapeutics Clinical Trial Data

Dyne Therapeutics announced additional one-year clinical data from the Phase 1/2 ACHIEVE trial of z-basivarsen (DYNE-101) for myotonic dystrophy type 1 (DM1), showing sustained functional improvement in myotonia, strength, and mobility. The data showed a 3.6-second relative improvement in hand myotonia at 6 months compared to placebo and divergence from a matched natural history cohort at 12 months. The company remains on track to report topline data from its registrational expansion cohort in Q1 2027 to support a potential BLA submission for U.S. Accelerated Approval in Q3 2027.

4:08 PM ET 8-K
Divestiture Century Casinos Inc CNTY

Century Casinos Divestiture to Highfield Investment Group Inc. for $16.4M

Century Casinos entered into a definitive agreement to sell the racing and gaming operations of Century Mile and Century Downs in Alberta, Canada, to Highfield Investment Group for approximately $16.4 million. The deal includes an amendment to the company's master lease with VICI Properties, reducing Century's annual rent by approximately $7.5 million. The company intends to use the proceeds to reduce its indebtedness and focus on its U.S. growth opportunities.

Value
$16.4M
Counterparty
Highfield Investment Group Inc.
4:08 PM ET 8-K
Capital Raise VistaOne, L.P.

VistaOne Capital Raise of $24.2M

VistaOne, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $24.2 million as part of its continuous private offering. The sale included Class B, I, R, and S units to third-party investors, with the final unit counts determined based on the Fund's transactional net asset value as of August 31, 2026.

Value
$24.2M
Counterparty
Third-party investors
4:07 PM ET 8-K
Divestiture Fox Factory Holding Corp FOXF

Fox Factory Holding Divestiture to Squared Up Holdings, LLC for $225M

Fox Factory Holding Corp. completed the divestiture of its Marucci Business (Wheelhouse Holdings Inc.) to Squared Up Holdings, LLC for an enterprise value of $225 million. The consideration consisted of $200 million in cash and a $25 million subordinated convertible promissory note, with the cash proceeds used to reduce the company's outstanding debt.

Value
$225M
Counterparty
Squared Up Holdings, LLC
4:06 PM ET 8-K
Contract Win Polar Power, Inc. POLA

Polar Power Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia

Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, marking the first phase of a potential five-year deployment program. The total opportunity covers approximately 2,500 sites and is estimated to be worth up to $60 million in revenue if the customer proceeds with the full rollout. The deal follows five years of technical evaluation and field testing aimed at reducing fuel and maintenance costs for off-grid cell sites.

Value
$60M
Counterparty
Major Tier 1 telecom operator in Southeast Asia
Term
5 years
4:06 PM ET 8-K
Contract Win Legacy Education Inc. LGCY

Legacy Education Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia

Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, representing the first phase of a potential five-year deployment program. If the customer proceeds with the full program covering 2,500 sites, the opportunity is estimated to represent approximately $60 million in revenue.

Value
$60M
Counterparty
Major Tier 1 telecom operator in Southeast Asia
Term
5 years
4:05 PM ET 8-K
M&A Deal Athena Technology Acquisition Corp. II ATEK

Athena Technology Acquisition Corp. II M&A Deal with Ace Green Recycling, Inc.

Athena Technology Acquisition Corp. II and Ace Green Recycling, Inc. entered into a waiver to their existing Business Combination Agreement to remove the requirement that SPAC warrants be listed on Nasdaq. The waiver was necessary because the warrants will not meet Nasdaq's minimum requirement of 100 round lot public holders.

Counterparty
Ace Green Recycling, Inc.
4:04 PM ET 8-K
Divestiture Braemar Hotels & Resorts Inc. BHR

Braemar Hotels & Resorts Divestiture to Evergreen Acquisitions, LLC for $372M

Braemar Hotels & Resorts Inc. entered into a definitive agreement to sell the Four Seasons Resort Scottsdale at Troon North to Evergreen Acquisitions, LLC for $372 million. The company has received a $10 million non-refundable deposit as part of the transaction, which remains subject to customary closing conditions.

Value
$372M
Counterparty
Evergreen Acquisitions, LLC
4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Maison Solutions Inc. MSS

Maison Solutions Nasdaq/NYSE Compliance Notice

Maison Solutions Inc. received a deficiency notice from Nasdaq on September 23, 2026, due to the late filing of its Quarterly Report on Form 10-Q and its Annual Report on Form 10-K. The company has until October 19, 2026, to submit a plan to regain compliance, which if accepted, could grant an extension until February 9, 2027.

Counterparty
The Nasdaq Stock Market LLC
2:44 PM ET 8-K/A
M&A Deal Catalyst Bancorp, Inc. CLST

Catalyst Bancorp M&A Deal with Lakeside Bancshares, Inc.

Catalyst Bancorp, Inc. filed a Form 8-K/A to provide required financial statements and pro forma information following its completed acquisition of Lakeside Bancshares, Inc. and Lakeside Bank. The filing includes audited financial statements for Lakeside for 2024-2025 and unaudited pro forma condensed combined financial statements as of March 31, 2026. This amendment supplements the original merger consummation report filed on July 14, 2026.

Counterparty
Lakeside Bancshares, Inc.
12:59 PM ET 8-K
Capital Raise Adams Street Credit Solutions Fund

Adams Street Credit Solutions Fund Capital Raise

Adams Street Credit Solutions Fund raised approximately $350,000 through the sale of 17,386.585 Class I common shares in its September 2026 monthly closing. The shares were issued at a price of $20.13 per share, representing the fund's net asset value as of August 31, 2026. The fund also declared a monthly distribution of $0.15 per share for Class I shareholders of record as of September 24, 2026.

10:31 AM ET 8-K
Capital Raise Silexion Therapeutics Corp SLXN

Silexion Therapeutics Capital Raise of $840K

Silexion Therapeutics entered into an inducement agreement with warrant holders to exercise 3,216,928 existing warrants at a reduced price of $0.2603 per share. In exchange for the cash exercise, the company will issue 6,433,856 new Series F and G warrants to the holders. The transaction is expected to generate gross proceeds of approximately $0.84 million to support the company's operations.

Value
$840K
Counterparty
H.C. Wainwright & Co., LLC
9:35 AM ET 8-K
Clinical Trial Data Oncolytics Biotech Inc ONCY

Oncolytics Biotech Clinical Trial Data

Oncolytics Biotech announced the publication of preclinical data in the Proceedings of the National Academy of Sciences demonstrating that its immunotherapy candidate, pelareorep, can transform immunologically inactive liver cancer tumors into active ones. The data showed pelareorep increased CD8+ T cell density and PD-L1 expression, potentially making challenging tumor types more susceptible to checkpoint inhibitors and other immunotherapies.

9:29 AM ET 8-K
M&A Deal Columbus Acquisition Corp COLAU

Columbus Acquisition M&A Deal with WISeSat.Space Corp

Columbus Acquisition Corp, a SPAC, has adjourned its Extraordinary General Meeting of Shareholders to September 30, 2026. The meeting is intended to vote on the proposed business combination with WISeSat.Space Corp, and the adjournment provides additional time for the company to finalize the process.

Counterparty
WISeSat.Space Corp
9:28 AM ET 8-K
Capital Raise CVC-PE Global Private Equity Fund, LP

CVC-PE Global Private Equity Fund Capital Raise of $79.9M

CVC-PE Global Private Equity Fund, LP raised approximately $79.9 million in aggregate consideration through the sale of unregistered limited partnership units on September 1, 2026. The capital raise was part of the Fund's continuous private offering, with units priced based on the Transactional Net Asset Value (NAV) as of August 31, 2026.

Value
$79.9M
9:21 AM ET 8-K
M&A Deal Creatd, Inc. CRTD

Creatd Signs $3.63M M&A Deal with C2 Capital Group, Inc. d/b/a C2 Live

Creatd, Inc. acquired a 10% equity stake in livestreaming platform C2 Live through a share exchange agreement valued at approximately $3.63 million. The company also signed a non-binding letter of intent to acquire the remaining 90% of C2 Live in the fourth quarter of 2026 as part of its AI and creator-driven growth strategy.

Value
$3.63M
Counterparty
C2 Capital Group, Inc. d/b/a C2 Live
9:16 AM ET 8-K
Nasdaq/NYSE Compliance Notice Liminatus Pharma, Inc. LIMN

Liminatus Pharma Nasdaq/NYSE Compliance Notice

Liminatus Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price above $1.00 for 13 consecutive trading days. The company previously effected a 1-for-50 reverse stock split on August 20, 2026, to address the deficiency. Nasdaq has officially closed the matter, and the company remains listed on The Nasdaq Capital Market.

Counterparty
Nasdaq
9:15 AM ET 8-K
M&A Deal Cohen & Steers Income Opportunities REIT, Inc. CNSREIT

Cohen & Steers Income Opportunities REIT M&A Deal with Grand Canyon Crossing Shopping Center

Cohen & Steers Income Opportunities REIT (CNSREIT) has acquired Grand Canyon Crossing, a 99%-occupied shopping center in Phoenix, Arizona, anchored by a high-performing Walmart Supercenter. The acquisition was made through a programmatic joint venture with the Sterling Organization. The deal aligns with CNSREIT's strategy of investing in income-generating retail assets anchored by necessity-based tenants in high-growth markets.

Counterparty
Grand Canyon Crossing Shopping Center
9:06 AM ET 8-K
Clinical Trial Data uniQure N.V. QURE

uniQure Clinical Trial Data

uniQure N.V. released a clinical program update for AMT-130 (ifezuntirgene inilparvovec), its gene therapy candidate for Huntington’s disease. The update includes long-term data from ongoing Phase I/II clinical trials and details regarding the enrollment of a fourth cohort. The company is also evaluating neurofilament light chain (NfL) in cerebrospinal fluid as a potential biomarker for disease severity.

8:45 AM ET 8-K
Clinical Trial Data Moleculin Biotech, Inc. MBRX

Moleculin Biotech Clinical Trial Data

Moleculin Biotech has completed and closed enrollment for Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for relapsed or refractory acute myeloid leukemia (R/R AML). The company enrolled 89 subjects and remains on track for a comprehensive data readout in the first quarter of 2027. The final Part A dataset is expected to provide efficacy insights across both 'fit' and 'unfit' patient populations, with an estimated 50/50 split between those previously treated with intensive chemotherapy versus venetoclax-based regimens.

8:45 AM ET 8-K
Contract Win Omniq Corp. OMQS

Omniq Wins Contract from Two Pennsylvania municipalities

OMNIQ Corp. secured its first deployments in Pennsylvania through two-year agreements with two municipalities to implement its Q Shield™ Safe City platform for vehicle registration enforcement. The projects involve 18 cameras across nine intersections and utilize a citation-based processing fee model, creating a transaction-based recurring revenue stream for the company.

Counterparty
Two Pennsylvania municipalities (a borough and a township)
Term
2 years
8:45 AM ET 8-K
M&A Deal Global Business Travel Group, Inc. GBTG

Global Business Travel Group Signs $6.3B M&A Deal with Long Lake Management

Global Business Travel Group (Amex GBT) completed its acquisition by Long Lake Management in an all-cash transaction valuing the company at approximately $6.3 billion. As a result of the merger, Amex GBT has become a privately held company and its Class A common stock will be delisted from the NYSE. The transaction was financed through a combination of equity from Long Lake investors and Koch Equity Development, along with a new $1.5 billion senior secured term loan facility.

Value
$6.3B
Counterparty
Long Lake Management
8:15 AM ET 8-K
Contract Win Flash Sports & Media Holdings, Inc. FLZH

Flash Sports & Media Holdings Wins $506K Contract from MindWave Innovations Inc.

Flash Sports & Media Holdings entered into a software development and technology services agreement with MindWave Innovations to build and operate 'FlashChain,' a dedicated blockchain network for sports media and ticketing. As consideration, the company will issue $506,000 in common stock and 20% of its FLASH TOKEN supply to MindWave. The partnership aims to authenticate digital broadcasting rights, video assets, and match-ticket inventory while preventing counterfeiting.

Value
$506K
Counterparty
MindWave Innovations Inc.
Term
12 months
8:01 AM ET 8-K
Licensing Deal Keros Therapeutics, Inc. KROS

Keros Therapeutics Licensing Deal with Takeda Pharmaceuticals U.S.A., Inc. Worth $20M

Keros Therapeutics announced it will receive a $20 million development milestone payment from its partner Takeda following the dosing of the first patient in the Phase 3 ELRiSE MF clinical trial for elritercept. The payment is part of a global license agreement that includes potential milestones exceeding $1.1 billion. Keros intends to distribute 25% of the net cash proceeds from this milestone to its stockholders.

Value
$20M
Counterparty
Takeda Pharmaceuticals U.S.A., Inc.
8:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice SurgePays, Inc. SURG

SurgePays Nasdaq/NYSE Compliance Notice

SurgePays received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, extending the deadline to March 22, 2027. Separately, Nasdaq confirmed the company has regained compliance with the minimum stockholders' equity requirement. The company intends to cure the bid price deficiency by effecting a reverse stock split if necessary.

Counterparty
The Nasdaq Stock Market LLC
Term
until March 22, 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.